As Drug Marketing Laws Proliferate In States, PhRMA Rejects Federal Option

State laws to restrict how pharmaceutical companies market their products to physicians are not yet so burdensome that industry is ready to support a federal scheme, Pharmaceutical Research and Manufacturers of America VP for Government Affairs Jan Faiks told the Food and Drug Law Institute's advertising and promotion conference Sept. 17